申请人:Burgess Laurence E.
                            
                            
                                公开号:US20110105463A1
                            
                            
                                公开(公告)日:2011-05-05
                            
                            Compounds of Formula (I): in which A
1
, A
2
, W, L, G, R
7a
, R
7b
, R
8
, R
9
and R
10
have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.
                            式(I)的化合物:其中A1、A2、W、L、G、R7a、R7b、R8、R9和R10的含义如规范中所述,是DP2受体调节剂,对治疗免疫疾病有用。